Retinoid inhibition of lingual carcinogenesis.
Sixty-four male and female Syrian hamsters, 3 months of age and weighing 90 to 120 grams, were divided into four equal experimental groups. In animals of Groups 1 and 2 the right posterior lateral border of the tongue was painted three times weekly with a 0.5 percent solution of DMBA in acetone. Group 2 animals also received 10 mg. of 13-cis-retinoic acid in peanut oil administered orally twice weekly by pipette. Carcinogen and retinoid were administered on alternate days. Group 3 animals received only 13-cis-retinoic acid. Group 4 animals served as untreated controls. Four animals in each group were killed at 12, 14, 16, and 18 weeks. The Group 2 animals, receiving 13-cis-retinoic acid, exhibited a significant delay in the development of lingual tumors, both grossly and microscopically. At 14 weeks carcinomas were found in the DMBA animals, but only dysplasia and areas of carcinoma in situ were found in the DMBA-retinoid animals. After 18 weeks the DMBA animals exhibited large lingual tumors with surfacenecrosis, while the DMBA-retinoid animals presented smaller tumors with less invasion of underlying tissue.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D002291:Carcinoma, Papillary / Q000139:chemically induced; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced; D006224:Cricetinae; D005260:Female; D015474:Isotretinoin; D007972:Leukoplakia, Oral / Q000473:pathology; D008297:Male; D008647:Mesocricetus; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control; D014059:Tongue / Q000473:pathology; D014062:Tongue Neoplasms / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D014212:Tretinoin / Q000627:therapeutic use*
D014212:Tretinoin; D015127:9,10-Dimethyl-1,2-benzanthracene; D015474:Isotretinoin